Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.

  • Creates late-stage, diversified pipeline that uses a multi-targeted approach to reset dysregulated biology to address considerable unmet needs
  • Combined pipeline extends from pre-clinical to registration studies, with near-term clinical and regulatory milestones
  • Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end

Continue reading

Breakthrough study uses genetic testing to evaluate risk of heart disease

(PHOENIX, Ariz. – Feb. 17, 2022) –Dignity Health in Arizona is launching the first research study  in North America in which genetic testing is used to identify men and women at risk of developing  heart disease based on the makeup of their DNA. If proven effective in clinical trials, this form of genetic testing may be adopted globally to prevent heart disease. Heart disease is the No. 1 killer in the world – in fact, half of Americans are expected to have at least one cardiac event in their lifetime. Continue reading

What Drives the Creation and Delivery of Cures and What Doesn’t

AZBio President & CEO, Joan Koerber-Walker,  shared insights with Duane Schulthess, Managing Director of Vital Transformation on the the Vital Health Podcast.  The popular podcast series has a global reach and features relaxed, one on one discussion with health care professionals, researchers, and regulators. Topics explore the implications of new medical procedures, technologies and policies as well as  their impact on current clinical practices.

Continue reading